- Home
- IMMP vs ANTA Comparison
IMMP vs ANTA Comparison
Compare IMMP & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- ANTA
- Stock Information
- Founded
- IMMP 1987
- ANTA 2022
- Country
- IMMP Australia
- ANTA Singapore
- Employees
- IMMP N/A
- ANTA N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- ANTA Investment Bankers/Brokers/Service
- Sector
- IMMP Health Care
- ANTA Finance
- Exchange
- IMMP Nasdaq
- ANTA Nasdaq
- Market Cap
- IMMP 251.8M
- ANTA 291.0M
- IPO Year
- IMMP N/A
- ANTA 2025
- Fundamental
- Price
- IMMP $1.93
- ANTA $11.50
- Analyst Decision
- IMMP Buy
- ANTA Strong Buy
- Analyst Count
- IMMP 1
- ANTA 2
- Target Price
- IMMP $7.00
- ANTA $19.25
- AVG Volume (30 Days)
- IMMP 208.1K
- ANTA 23.0K
- Earning Date
- IMMP 10-10-2025
- ANTA 12-17-2025
- Dividend Yield
- IMMP N/A
- ANTA N/A
- EPS Growth
- IMMP N/A
- ANTA N/A
- EPS
- IMMP N/A
- ANTA 0.24
- Revenue
- IMMP $3,306,742.00
- ANTA $56,997,910.00
- Revenue This Year
- IMMP $16.82
- ANTA $65.94
- Revenue Next Year
- IMMP N/A
- ANTA $59.39
- P/E Ratio
- IMMP N/A
- ANTA $47.20
- Revenue Growth
- IMMP 31.28
- ANTA 405.62
- 52 Week Low
- IMMP $1.32
- ANTA $10.19
- 52 Week High
- IMMP $2.71
- ANTA $27.72
- Technical
- Relative Strength Index (RSI)
- IMMP 45.60
- ANTA N/A
- Support Level
- IMMP $1.88
- ANTA N/A
- Resistance Level
- IMMP $2.08
- ANTA N/A
- Average True Range (ATR)
- IMMP 0.10
- ANTA 0.00
- MACD
- IMMP -0.03
- ANTA 0.00
- Stochastic Oscillator
- IMMP 4.97
- ANTA 0.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.